These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7686286
1. [Use of G-CSF in chemotherapy of urogenital cancers]. Droz JP, Théodore C. Pathol Biol (Paris); 1993 Jan; 41(1):48-9. PubMed ID: 7686286 [No Abstract] [Full Text] [Related]
2. [Present and future indications of G-CSF in breast cancer]. Chevallier B. Pathol Biol (Paris); 1993 Jan; 41(1):47. PubMed ID: 7686285 [No Abstract] [Full Text] [Related]
3. [Small cell lung cancer: value of G-CSF]. Trillet V. Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284 [No Abstract] [Full Text] [Related]
4. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF, Chan HO. Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [Abstract] [Full Text] [Related]
5. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia. Ghalaut PS, Sen R, Dixit G. J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972 [Abstract] [Full Text] [Related]
6. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group. Ozkaynak MF, Krailo M, Chen Z, Feusner J. Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544 [Abstract] [Full Text] [Related]
7. [Place of CSF in pediatric oncology]. Hartmann O, Valteau-Couanet D. Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289 [No Abstract] [Full Text] [Related]
11. The effect of granulocyte colony-stimulating factor (G-CSF) on the activity of granulocyte enzymes in children with cancer who developed neutropenia after chemotherapy. Czygier M, Dakowicz L, Szmitkowski M. Adv Med Sci; 2008 Jan; 53(2):278-82. PubMed ID: 18614436 [Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review. Bhana N. Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795 [Abstract] [Full Text] [Related]
14. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases. Kavgaci H, Ozdemir F, Aydin F, Yavuz A, Yavuz M. J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092 [Abstract] [Full Text] [Related]
15. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia. Hung MJ, Wang CH, Cherng WJ. Int J Clin Pract; 2002 Dec; 56(1):70-1. PubMed ID: 11831843 [Abstract] [Full Text] [Related]
20. Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization. Crea F, Giovannetti E, Zinzani PL, Danesi R. Crit Rev Oncol Hematol; 2009 Oct; 72(1):21-44. PubMed ID: 19111474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]